Evidence method
Level · gp.fundamentals.capex_revenue_ratio
251.15% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ABCL · Mar 31, 2025
AbCellera Biologics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-25-023836General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-272.82% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-57.45% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-1479.57% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1003.45% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
349.14% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History18 statesSelf-history eligible
Mar 31, 20220/6 normalizedLevel 3Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20235/6 normalizedLevel 3Sep 30, 20235/6 normalizedLevel 3Dec 31, 20235/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Sep 30, 20246/6 normalizedLevel 3Dec 31, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Sep 30, 20256/6 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 271.90%
- Current
- 251.15%
- Delta
- -20.75%
- Previous
- -376.50%
- Current
- -272.82%
- Delta
- 103.68%
- Previous
- -24.17%
- Current
- -57.45%
- Delta
- -33.28%
- Previous
- -1091.69%
- Current
- -1479.57%
- Delta
- -387.89%
- Previous
- 580.10%
- Current
- 1003.45%
- Delta
- 423.35%
- Previous
- 234.39%
- Current
- 349.14%
- Delta
- 114.75%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ABCL Fundamental State →Analogous To · ABCL state analogue 1 →Transitioned To · ABCL Fundamental State →Transitioned To · ABCL CAPEX_INTENSITY_DECREASED →Transitioned To · ABCL CASH_GENERATION_INCREASED →Transitioned To · ABCL GROWTH_DECREASED →Transitioned To · ABCL PROFITABILITY_DECREASED →Transitioned To · ABCL R_AND_D_INTENSITY_INCREASED →Transitioned To · ABCL SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.